Peter Maag
CIK 1613855 · Executive Chair · last filed 2025-07-10
Peter Maag is an Executive Chair who has filed 115 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider sold $185.8K of CDNA on Jul 10, 2025. Across all open-market trades the lifetime net is −$48.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.12M
2
115
-$47.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDNA | Director | 309,846 | $22.97 | $7.12M | -$48.01M | 110 | 2025-07-10 |
| Miromatrix Medical Inc. (MIRO) Delisted | Director | 0 | $3.39 | $0 | $50.0K | 5 | 2023-12-13 |
Recent Filings
115 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-10 | CDNA | Sell (S) | −10,000 | -$185.8K | EDGAR |
| 2025-06-20 | CDNA | Sell (S) | −10,000 | -$192.4K | EDGAR |
| 2025-06-17 | CDNA | Grant (A) | +12,103 | $0 | EDGAR |
| 2025-05-02 | CDNA | Sell (S) | −13,281 | -$228.8K | EDGAR |
| 2024-12-03 | CDNA | Mixed | — | -$63.8K | EDGAR |
| 2024-08-22 | CDNA | Mixed | −8,844 | -$961.9K | EDGAR |
| 2024-07-10 | CDNA | Grant (A) | +1,034 | $0 | EDGAR |
| 2024-06-20 | CDNA | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | CDNA | Grant (A) | +10,570 | $0 | EDGAR |
| 2024-05-01 | CDNA | Exer (M) | +13,281 | $70.0K | EDGAR |